Method and apparatus for predicting the presence of...

Details Method and apparatus for predicting the presence of... Method and apparatus for predicting the presence of...

2005-05-24

2005-05-24

Wachsman, Hal (Department: 2857)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Chemical analysis

C702S019000, C702S030000, C702S032000, C703S011000

Reexamination Certificate

active

06898532

ABSTRACT:
A method is disclosed for predicting the presence of haemostatic dysfunction. At least one time-dependent measurement on an unknown sample is performed and a respective property of the sample is measured over time so as to derive a time-dependent measurement profile. One or more predictor variables, including initial slope, are defined which sufficiently define the data of the time-dependent measurement profile. A model is then derived that represents the relationship between the abnormality and the set of predictor variables. Subsequently, the model is utilized to predict haemostatic dysfunction, such as septicemia or disseminated intravascular coagulation (DIC).

REFERENCES:
patent: 3307392 (1967-03-01), Owen et al.
patent: 3458287 (1969-07-01), Gross et al.
patent: 3658480 (1972-04-01), Kane et al.
patent: 4040788 (1977-08-01), Simons et al.
patent: 4047890 (1977-09-01), Eichelberger et al.
patent: 4199748 (1980-04-01), Bacus
patent: 4217107 (1980-08-01), Saito et al.
patent: 4279616 (1981-07-01), Saito et al.
patent: 4289498 (1981-09-01), Baughman et al.
patent: 4766083 (1988-08-01), Miyashita et al.
patent: 4782014 (1988-11-01), Serban et al.
patent: 4902630 (1990-02-01), Bennett et al.
patent: 4965725 (1990-10-01), Rutenberg
patent: 4998535 (1991-03-01), Selker et al.
patent: 5003065 (1991-03-01), Merritt et al.
patent: 5055412 (1991-10-01), Proksch
patent: 5156974 (1992-10-01), Grossman et al.
patent: 5169786 (1992-12-01), Carroll et al.
patent: 5218529 (1993-06-01), Meyer et al.
patent: 5221628 (1993-06-01), Anderson et al.
patent: 5358852 (1994-10-01), Wu
patent: 5388164 (1995-02-01), Yonekawa et al.
patent: 5473551 (1995-12-01), Sato et al.
patent: 5473732 (1995-12-01), Chang
patent: 5500345 (1996-03-01), Soe et al.
patent: 5506146 (1996-04-01), Josef
patent: 5525477 (1996-06-01), Hassouna
patent: 5526111 (1996-06-01), Collins et al.
patent: 5553616 (1996-09-01), Ham et al.
patent: 5563983 (1996-10-01), Nozaki et al.
patent: 5567596 (1996-10-01), Diamond et al.
patent: 5591403 (1997-01-01), Gavin et al.
patent: 5593897 (1997-01-01), Potempa et al.
patent: 5646046 (1997-07-01), Fischer et al.
patent: 5670329 (1997-09-01), Oberhardt
patent: 5705395 (1998-01-01), Griffin et al.
patent: 5708591 (1998-01-01), Givens et al.
patent: 5715821 (1998-02-01), Faupel
patent: 5716795 (1998-02-01), Matschiner
patent: 5834223 (1998-11-01), Griffin et al.
patent: 5856114 (1999-01-01), Mann et al.
patent: 5862304 (1999-01-01), Ravdin et al.
patent: 5981285 (1999-11-01), Carroll et al.
patent: 6010911 (2000-01-01), Baugh et al.
patent: 6040147 (2000-03-01), Ridker et al.
patent: 6101449 (2000-08-01), Givens et al.
patent: 6156530 (2000-12-01), R.ang.nby
patent: 6269313 (2001-07-01), Givens et al.
patent: 6321164 (2001-11-01), Braun et al.
patent: 2635081 (1978-02-01), None
patent: 3502 878 (1985-01-01), None
patent: 0 115 459 (1984-08-01), None
patent: 0 525 273 (1993-02-01), None
patent: 818 680 (1998-01-01), None
patent: 841 566 (1998-05-01), None
patent: 2364 453 (1976-09-01), None
patent: 0 434 377 (1991-06-01), None
patent: 2005014 (1979-04-01), None
patent: 59-203959 (1984-11-01), None
patent: 60-114768 (1985-06-01), None
patent: 61-272655 (1986-12-01), None
patent: 05-180835 (1991-12-01), None
patent: 06-027115 (1992-07-01), None
patent: 04-254760 (1992-09-01), None
patent: 06-249855 (1994-09-01), None
patent: 10-104239 (1996-09-01), None
patent: 2012877 (1991-04-01), None
patent: 2061953 (1996-06-01), None
patent: 2070327 (1996-12-01), None
patent: 590665 (1976-02-01), None
patent: 1076086 (1984-02-01), None
patent: 1691741 (1989-08-01), None
patent: 1777089 (1990-06-01), None
patent: WO 8606840 (1986-11-01), None
patent: WO 8909628 (1989-10-01), None
patent: WO 9100872 (1991-01-01), None
patent: WO 9101383 (1991-02-01), None
patent: WO 9101497 (1991-02-01), None
patent: WO 9102812 (1991-03-01), None
patent: WO 9105874 (1991-05-01), None
patent: WO 9108460 (1991-06-01), None
patent: WO 9116453 (1991-10-01), None
patent: WO 9307491 (1993-04-01), None
patent: WO 9309438 (1993-05-01), None
patent: WO 9324530 (1993-12-01), None
patent: WO 9407145 (1994-03-01), None
patent: WO 9411714 (1994-05-01), None
patent: WO 9416095 (1994-07-01), None
patent: WO 9505590 (1995-02-01), None
patent: WO 9508121 (1995-03-01), None
patent: WO 9642018 (1995-09-01), None
patent: WO 9530154 (1995-11-01), None
patent: WO 9606624 (1996-03-01), None
patent: WO 9614581 (1996-05-01), None
patent: WO 9621740 (1996-07-01), None
patent: WO 9641291 (1996-12-01), None
patent: WO 9704317 (1997-02-01), None
patent: WO 9720066 (1997-06-01), None
patent: WO 9734698 (1997-09-01), None
patent: WO 9809628 (1998-03-01), None
patent: WO 9934208 (1999-07-01), None
patent: WO 9947699 (1999-09-01), None
Downey et al., “Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis”, Thromb. Haemost 1998; 80: 65-9, (No month).*
3×15 Test Kit for Detection of Plasma Protein C Activity Using a Clotting End-Point, Product #ACC-45,American Diagnostica Inc.,1-2 (Feb. 1989).
Artherotech, VAP/CAD Lipoprotein Risk Assessment Tes and Sample of VAP Profile, http://www.artherotech.com/risk_assesment.html (10 pages), (No date).
Astion, et al., Overtraining in neural networks that interpret clinical data,.Clin.Chem.,39(9):1998-2004 (1993), (No month).
Astion, et al., The application of backpropagation neural networks to problems in pathology and laboratory medicine,Arch Pathol. Lab. Med.,116:995-1001 (Oct. 1992).
Baum and Haussler, What size net gives valid generalization?,Neural Computation,pp. 81-89 (Jan. 1989).
Baumann, et al., Computerized analysis of the in vitro activation of the plasmatic clotting system,Haemostasis,19:309-321 (1989), (No month).
Bluestein and Archer, The sensitivity, specificity and predictive value of diagnostic information: a guide for clinicians,Nurse Practitioner,16(7):39-45 (Jul. 1991).
Boone et al., Neural networks in radiologic diagnosis,Investigative Radiology,25(9):1013-1023 (Sep. 1990).
Brandt, et al., Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologies survey program,Arch. Pathol.Lab.Med.,115:109-114 (Feb. 1991).
Braun et al., Examination of prothrombin time (PT) and activated partial thromboplastin time (APTT) optical clot profiles using an automated thrombosis-hemostasis,Coagulation Methods Instrumentation and Quality Control,p. 1236, Abstract #1286 (1995), (No month).
Braun, et al., Properties of optical data from activated partial thromboplastin time and prothrombin time assays,Thromb Haemost.,78: 1079-1087 (1997), (No month).
Cabana, et al., Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins,J.Lipid.Res.,30 (1989), (Abstract only), (No month).
Cabana, et al., Inflammation-induced changes in rabbit CRP and plasma lipoproteins,J.Immunol.,130(4) (Apr. 1983), (Abstract only).
Cabana, et al., Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein,J. Immunol.,128 (May 1982), (Abstract only).
Canivet, et al.,Postoperative changes in lipid profile: their relations with inflammatory markers and endocrine mediators, Acta Anesthesiol.Belg.,40(4):263-268 (1989), no month.
Carrol, et al., Ortho Educational Monograph,The Clot Signature and New Aspects in Coagulation Testing,Ortho Diagnostic Systems, Inc., p. 1-20 (1989).
Christner and Mortensen, Specificity of the binding interactions between human serum amyloid P-component and immobilized human C-reactive protein,J.Biol.Chem.,269(13) (Apr. 1994), (Abstract only).
Dassen, et al., Self-learning neural networks in electrocardiography,J. Electrocardiol.,23 Suppl:200-202 (1990), (No month).
de Beer, et al., Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein,J.Exp.Med.,156 (Jul. 1982), (Abstract only).
Dennis et al., Utility of prothrombin time waveform analysis in the routine clinical setting,Abstract Instruction and Submission Form,(Sep. 1999).
Downey et

Affiliated with

Also associated with

Rating

Method and apparatus for predicting the presence of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and apparatus for predicting the presence of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for predicting the presence of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3440607